What is CTX Technology & How To Invest? [Elon Musk CTX Stock]

Wondering what Elon Musk’s CTX Technology is as pitched by Jeff Brown?

Jeff Brown’s Brownstone Research just released a new presentation titled “Elon’s ‘Final Act’” where he sat with Chris Hurt to discuss his latest research into what he calls CTX tech.

The header reads:

“From a Tesla factory spitting out strange “RNA” codes… to an unlikely alliance between two rivals… the signs are clear. The world is revving up for a once-in-a-lifetime transformation. Those who invest on the ground floor today could have the chance at generational wealth.”

In this article, we learn more about Jeff Brown’s CTX Technology prediction, and why he believes that we are about to see a once-in-a-lifetime transformation.

Before I start…

If you’re tired of scams and want a real solution for making money online check out my no.1 recommendation.

It’s helped me earn over $300,000 in the last 12 months alone:

Go here to see my no.1 recommendation for making money online

(This is a 100% free training)

What is CTX Technology?

Table of Contents

Introduction to CTX Technology

Jeff Brown’s CTX Technology pitch is about a new biotech development that he thinks has opened a financial opportunity of a lifetime. CTX should not be confused with other pitches by Jeff recently such as GTE and SCG. Neither should it be confused for CTX Technology inc.

He starts the presentation by telling us that according to Reuters, a Tesla factory 400 miles southwest of Berlin has stopped making cars and has started making biotech devices instead—known as “RNA molecule printers.”

According to Jeff, Tesla’s entry into biotech signifies the advent of a “renaissance” like the one we saw in the 90s when biotech stocks like Gilead Sciences went up by as much as 56,000%.

He says that Elon Musk predicted that biotech could change the world when he was in college in 1992 when he was 21 years old, and the move by one of Tesla’s factories to produce biotech devices is a sign that he is following up on that.

He says that “CTX” technology could be “the beginning of the end of disease as we know it.”

Why, because it would allow us to cure illnesses without surgery or pills.

“It’s just one injection, Chris. And that’s it. Forever.”

Jeff Brown quotes The Wall Street Journal that indicated that “CTX” could soon help “millions with heart disease, chronic pain, and other conditions.”

As it turns out, Jeff Brown is talking about Crispr (this is what he calls CTX technology).

CRISPR is a technology that can be used to edit genes. It is a way of finding a specific bit of DNA inside a cell. The next step is CRISPR gene editing and it usually involves altering that piece of DNA.

It is considered the next frontier in biology because it could allow us to cure diseases. We will have the ability to edit genetic material to produce desired outcomes.

Jeff Brown says that the Tesla factory he is referring to is making biotech devices for a company backed by Bill Gates. Mr. Gates has poured hundreds of millions of dollars into “CTX” technology, according to Jeff.

Besides Musk and Gates, a former President of Facebook wrote a nine-figure check for “CTX.” Jeff Bezos is also involved.

In addition to that, Jeff says that major universities across the world have activated departments to study “CTX,” major corporations you wouldn’t expect like Google are now pouring funds directly into “CTX,” and the US government is now getting in.

He also says that the FDA has issued special designations setting “CTX” apart from ordinary biotech breakthroughs.

Investing in CTX

Jeff Brown says that you should start investing in the stocks driving CRISPR forward.

“The genesis launch of “CTX” is “CTX #1” — I call it that because that’s the codename it’s been using in trials.

The FDA is already waving this through. It has four green light designations, including “Fast Track”, “Orphan Drug” and “Rare Disease” status. Europe has granted 2 of its own green lights as well. They are practically announcing to us, “We are pushing this thing through, very fast.” You don’t usually get that kind of “heads up” in the biotech world…

And my research tells me this is just the very beginning of a broader revolution.”

He has identified one company that owns CTX #1. He has placed that company’s name and stock symbol in a report titled The Biotech Revolution: Stocks to Own Right Away.

This report has a list of companies:

“One, a small biotech firm that’s produced the most important scanner since the X-ray was invented in the 1800s… one that feeds directly into “CTX” technology.

Two, a company using “CTX” as a base for what could be the world’s most groundbreaking cancer cure.

And three, a company whose team has secured six FDA-approved treatments in the past. They are now entering the world of “CTX.” If what they’re working on next hits just 10% of its target market… it will make $4 billion per year. It hits a bit over 50%… that would make it the best-selling biotech product in the world.”

To get a copy of the report, you have to sign up for Jeff Brown’s The Near Future Report.

Who is Jeff Brown?

Jeff Brown is an investment analyst who edits newsletters at Brownstone Research, a boutique financial research firm that he created in 2020.

He has a deep background in the tech industry. For decades he worked as a senior executive at some of the top tech companies in the world. This includes Qualcomm and NXP Semiconductors as well as stints at Juniper Networks and Boeing.

Jeff Brown holds credentials from MIT, Yale, Purdue’s “Cradle of Astronauts”, and London Business School.

Jeff is also an angel investor and he’s done about three hundred deals in the world of private technology and biotechnology.

He has appeared on news networks like Breitbart and sat down for interviews about technology and artificial intelligence with huge names like Glenn Beck. He has also served in the Chamber of Digital Commerce.

Jeff Brown is hands-on with his research. For example, when he was researching CRISPR, he flew 3,000 miles to a small lab in California. He held a meeting to learn more about “CTX”.

How does The Near Future Report Work?

The Near Future Report is Jeff Brown’s flagship financial research service. He created it because he believes that technology today moves faster than most people can keep up with.

He leverages his background as a tech executive, angel investor, and full-time analyst to give retail investors access to analysis usually reserved for professional investors and traders.

Every month, Jeff publishes a new issue of The Near Future Report.

When you sign up for it, you get:

One year of the Near Future Report. This includes 12 issues of the newsletter covering the latest trends in technology and finance.
A Full Library of Reports on Every Major Tech Trend of Today. You gain access to a collection of investment recommendations from every aspect of the tech world.
Unrestricted Access to The Near Future Report’s Model Portfolio. The model portfolio has every open recommendation by Jeff so far. You can get in on every single pick that is still on Jeff’s list.
24/7 Access to The Near Future Report’s Members-Only Website. You gain access to all past newsletter issues, special reports, and other member benefits.
Customer Support from the Florida-Based Team. Jeff’s team is headquartered in Delray Beach, Florida, and available by phone or email, Monday – Friday, 9 am to 7 pm ET.

You also gain access to two extra special reports with other opportunities. They are

How to Invest in Tesla’s Secret Supplier

Jeff believes that whether Tesla continues to dominate the EV market or whether smaller startups come in and disrupt it, this small firm that he alleges is a Tesla supplier will survive.

He says that as the auto world goes electric, this small firm will go with it because electric vehicles cannot move without the crucial piece of technology this company creates.

He adds that this company is not stopping at EVs because it will provide a platform for Artificial Intelligence, 5G, Solar Power, and Satellite Internet.

Your 101 Guide to Striking it Rich in the NFT Gold Rush

Jeff Brown believes that NFTs are the next logical step after cryptocurrency. He’s even done a presentation about them called “NFT Moment Coins.”

He says that if you would like to know how to invest in them early, he has prepared a list of specific steps you can take right away.

He even claims that you don’t have to go buy NFTs or cryptocurrency if you don’t want to because he’ll show you strategies you can use in your regular brokerage account.

The Near Future Report Subscription Price and Refund Policy

An annual subscription costs $129 (only the first year costs $49) and it comes with a 60-day money-back guarantee.

Jeff Brown CTX Technology Verdict

Jeff Brown’s CTX Technology presentation is all about CRISPR technology, which is considered one of the next great frontiers in biology. Scientists believe that CRISPR, which is the ability to edit the genome of a living cell, holds enormous potential to accelerate biology as we know it.

Many people speculate that it will change other industries too.

Although there have been ethical debates about its use, a lot of research is going into it and the companies involved will benefit from that.

At this point, it is hard to tell how the market will pan out but Jeff’s insights are worth examining if you are looking for cover in that subsector.

Before you leave

If you’re tired of scams and want a real solution for making money online check out my no.1 recommendation.

It’s helped me earn over $300,000 in the last 12 months alone:

Go here to see my no.1 recommendation for making money online

(This is a 100% free training)

David Fortune

David Fortune has been the editor NoBSIMReviews.com since 2019. He is an expert at writing content on stock advisory services, side hustles, reviewing online business opportunities and many more topics. You can learn more about David on our about us page.

Go here to see the best business to start in 2024